Novaplus Logo (Novaplus Logo)
Eribulin Mesylate Injection
Product Images NDC 60505-6435
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 60505-6435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Eribulin-spl-carton-label (Eribulin Spl Carton Label)
Packaging label for Eribulin Mesylate Injection 1 mg/2 mL (0.5 mg/mL) sterile solution for intravenous use. The label shows a single-dose vial containing 2 mL. Manufactured by Clad Pharma Limited, labeled for Apotex Corp. The label includes dosing, storage instructions, and a barcode along with the NovaPlus logo.*
Eribulin-spl-fig-1 (Eribulin Spl Fig 1)
A Kaplan-Meier survival curve comparing eribulin mesylate treatment to a control. The graph shows the proportion of patients surviving over time in months, with eribulin mesylate represented by a higher survival curve than the control group. The number of patients at risk is indicated below the horizontal axis at various time points.*
Eribulin-spl-fig-2 (Eribulin Spl Fig 2)
A survival curve graph comparing survival probability over time (in months) between eribulin mesylate and dacarbazine treatments. The graph includes two lines representing each treatment, with survival probability on the y-axis and survival time in months on the x-axis. A table below the graph shows the number of subjects at risk at various time points for each treatment group.*
Eribulin-spl-structure (Eribulin Spl Structure)
Chemical structure of eribulin mesylate is shown in this image, depicting its detailed molecular arrangement including various atoms and bonds typical of this complex compound.*
Eribulin-spl-vial-label (Eribulin Spl Vial Label)
Label for Eribulin Mesylate Injection by Apotex Corp. The injectable solution contains 1 mg per 2 mL (0.5 mg/mL) strength. It is for intravenous use and supplied as a single-dose vial with instructions to discard unused portions. The label includes storage directions and a barcode with NDC 60505-6435-0.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
